The ENTERO2024 conference, organized by Digestive Cancers Europe (DiCE), convened at the European Parliament in Brussels to address the alarming rise in digestive cancer incidences.

Over the past three decades, early age-onset cases of digestive cancers, including colorectal, oesophageal, gastric, pancreatic, and biliary cancers, have surged by 80%, with many patients diagnosed before the age of 40.

Colorectal cancer has become the leading cause of cancer death among men aged 20-49 in the U.S., prompting discussions on lowering the screening age to 45 and enhancing training for healthcare providers.

Participants at the conference urged the European Union to reconsider its strategies for screening, treatment, and support for digestive cancers, especially among young adults.

Aurelijus Veryga, a former Lithuanian health minister, emphasized that the discussions serve as a call to action, highlighting the urgent need for immediate responses to prevent lives lost due to late diagnoses.

Patient testimonies, such as that of Mila Ollaga Toledo, reveal that many young adults experience treatment delays because their symptoms are often trivialized, with 60% diagnosed at advanced stages.

Eric Van Cutsem stressed the importance of harmonizing efforts among EU member states to enhance access to clinical research and innovative treatments, pointing out bureaucratic hurdles as a significant barrier.

Access to innovative treatments remains complicated, as over 70% of young patients are unaware of clinical trial opportunities, with many not informed about participation possibilities by their healthcare providers.

Psychological support is vital for young cancer patients, with up to 60% experiencing psychological distress; structured support can significantly improve both quality of life and survival rates.

The conference underscored the need for research into environmental-genetic interactions and the development of non-invasive screening strategies specifically tailored for young adults.

Vytenis Povilas Andriukaitis, a member of the European Parliament, criticized the current screening approach, advocating for risk-based screening instead of age-based methods and calling for increased funding for cancer research.

Zorana Maravic, CEO of DiCE, highlighted the necessity for increased awareness, interdisciplinary research, and equitable access to treatment as key priorities for the EU in tackling digestive cancers among young adults.